USPTO patent application


In collaboration with Martin Pomper group (Johns Hopkins Medical Institutions, Baltimore, USA) we filed a USPTO describing the development of new monoclonal antibodies recognizing human prostate-specific membrane antigen. The antibodies can be used for imaging and therapy of prostate cancer and solid tumors. Further development and licensing is in progress.